HAE — Haemonetics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Haemonetics, fiscal year end - March 29th, USD millions except per share, conversion factor applied.

	2021 April 3rd	2022 April 2nd	2023 April 1st	2024 March 30th	2025 March 29th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	192	259	284	179	307
Net Total Accounts Receivable
Net Total Receivables	128	159	179	207	203
Total Inventory
Prepaid Expenses
Total Current Assets	694	756	770	769	935
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	277	311	364	367	332
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,820	1,860	1,935	2,196	2,451
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	253	442	252	300	578
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,088	1,110	1,117	1,236	1,630
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	732	749	818	960	821
Total Liabilities & Shareholders' Equity	1,820	1,860	1,935	2,196	2,451
Total Common Shares Outstanding